Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin
Background. Neuropathic pain is widely recognized as one of the most difficult pain syndromes to treat and presents a significant challenge for pain clinicians and GPs. Methods. The Self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire, recently validated for ident...
Gespeichert in:
| Veröffentlicht in: | Family practice 2007-10, Vol.24 (5), p.481-485 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 485 |
|---|---|
| container_issue | 5 |
| container_start_page | 481 |
| container_title | Family practice |
| container_volume | 24 |
| creator | Torrance, Nicola Smith, Blair H Watson, Margaret C Bennett, Michael I |
| description | Background. Neuropathic pain is widely recognized as one of the most difficult pain syndromes to treat and presents a significant challenge for pain clinicians and GPs. Methods. The Self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire, recently validated for identifying pain of predominantly neuropathic origin (POPNO), was sent to 6000 adults identified from general practices in the UK. The questionnaire also contained items about chronic pain identification, medications and treatments received for pain and the pain relief these provided. Results. In total, 1420/3002 (48%) of respondents indicated that they suffered with any chronic pain. These were further categorized as those with chronic pain who were S-LANSS negative [‘chronic pain (non-POPNO)’ group, n = 1179] and those with chronic pain who were S-LANSS positive, indicating the presence of POPNO (‘chronic POPNO’ group, n = 241). Questions relating to treatments and medications were completed by 88% of the respondents (1244/1420). The chronic POPNO group was more likely to receive multiple pain medications (37% versus 21% took two or more pain medications, P |
| doi_str_mv | 10.1093/fampra/cmm042 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68505835</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/fampra/cmm042</oup_id><sourcerecordid>20922415</sourcerecordid><originalsourceid>FETCH-LOGICAL-c515t-61b62fa2a955d3779bf26839aacdf3cb823a8ad6d079bad639c7f4009231c8733</originalsourceid><addsrcrecordid>eNqF0c9rFDEUB_AgFrtWj14leBAv0-bH5NdRqu4KrV5UxEvIZjJu2p1kmmSw_e_NMoMFL3t6kPfJeyRfAF5hdI6Rohe9GcZkLuwwoJY8ASvcctQQQtRTsEKE04Zgyk_B85xvEEJCMPEMnGLBBZKoXYHba9d5a4qPAZrQwZKcKYMLBU7ZQR_gmPxg0gO0Jjk4Vlh7Gf7xZQftLsXgbT2tLvaVui4OPphQ9g8wuCnFemFXRUz-tw8vwElv9tm9XOoZ-P7p47fLTXP1df358v1VYxlmpeF4y0lviFGMdVQIte0Jl1QZY7ue2q0k1EjT8Q7VVq1UWdG3CClCsZWC0jPwdp47png3uVz04LN1-70JLk5Zc8kQk5QdhUwQhhXlRyGpy0mLDxPf_Adv4pRCfa3GSrGq5AE1M7Ip5pxcr5dP1hjpQ6h6DlXPoVb_ehk6bQfXPeolxQrezSBO49FZy26fi7v_h0261VxQwfTm5y-9_vBlfS03P_Sa_gUuUb0X</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199592285</pqid></control><display><type>article</type><title>Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin</title><source>MEDLINE</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Torrance, Nicola ; Smith, Blair H ; Watson, Margaret C ; Bennett, Michael I</creator><creatorcontrib>Torrance, Nicola ; Smith, Blair H ; Watson, Margaret C ; Bennett, Michael I</creatorcontrib><description>Background. Neuropathic pain is widely recognized as one of the most difficult pain syndromes to treat and presents a significant challenge for pain clinicians and GPs. Methods. The Self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire, recently validated for identifying pain of predominantly neuropathic origin (POPNO), was sent to 6000 adults identified from general practices in the UK. The questionnaire also contained items about chronic pain identification, medications and treatments received for pain and the pain relief these provided. Results. In total, 1420/3002 (48%) of respondents indicated that they suffered with any chronic pain. These were further categorized as those with chronic pain who were S-LANSS negative [‘chronic pain (non-POPNO)’ group, n = 1179] and those with chronic pain who were S-LANSS positive, indicating the presence of POPNO (‘chronic POPNO’ group, n = 241). Questions relating to treatments and medications were completed by 88% of the respondents (1244/1420). The chronic POPNO group was more likely to receive multiple pain medications (37% versus 21% took two or more pain medications, P < 0.001) and stronger painkillers [e.g. opioids odds ratio 1.94; 95% confidence interval 1.10, 3.42]. Despite this, they reported less effective pain relief than the non-POPNO chronic pain group. Conclusion. Patients in primary care reporting chronic pain were found generally to obtain incomplete relief from their medication with chronic POPNO patients reporting less relief. It is important that patients with any chronic pain are identified and managed appropriately according to their distinct treatment needs.</description><identifier>ISSN: 0263-2136</identifier><identifier>EISSN: 1460-2229</identifier><identifier>DOI: 10.1093/fampra/cmm042</identifier><identifier>PMID: 17670804</identifier><identifier>CODEN: FAPREH</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adult ; Aged ; Analgesics - therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Anticonvulsants - therapeutic use ; Antidepressive Agents - therapeutic use ; Central Nervous System Agents - therapeutic use ; Chronic Disease ; Chronic pain ; Drugs ; Female ; Health Surveys ; Humans ; Male ; Middle Aged ; Neuralgia - drug therapy ; Neuralgia - epidemiology ; Neuralgia - therapy ; neuropathic pain ; Opioids ; Outcome and Process Assessment (Health Care) ; Pain Measurement ; Parasympatholytics - therapeutic use ; Physical Therapy Modalities - utilization ; Prevalence ; primary care ; Primary health care ; Primary Health Care - methods ; Relief ; S-LANSS ; Severity of Illness Index ; treatment ; United Kingdom - epidemiology ; Urban Health</subject><ispartof>Family practice, 2007-10, Vol.24 (5), p.481-485</ispartof><rights>The Author 2007. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org. 2007</rights><rights>The Author 2007. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c515t-61b62fa2a955d3779bf26839aacdf3cb823a8ad6d079bad639c7f4009231c8733</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,1579,27905,27906,30981</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17670804$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Torrance, Nicola</creatorcontrib><creatorcontrib>Smith, Blair H</creatorcontrib><creatorcontrib>Watson, Margaret C</creatorcontrib><creatorcontrib>Bennett, Michael I</creatorcontrib><title>Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin</title><title>Family practice</title><addtitle>Fam Pract</addtitle><description>Background. Neuropathic pain is widely recognized as one of the most difficult pain syndromes to treat and presents a significant challenge for pain clinicians and GPs. Methods. The Self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire, recently validated for identifying pain of predominantly neuropathic origin (POPNO), was sent to 6000 adults identified from general practices in the UK. The questionnaire also contained items about chronic pain identification, medications and treatments received for pain and the pain relief these provided. Results. In total, 1420/3002 (48%) of respondents indicated that they suffered with any chronic pain. These were further categorized as those with chronic pain who were S-LANSS negative [‘chronic pain (non-POPNO)’ group, n = 1179] and those with chronic pain who were S-LANSS positive, indicating the presence of POPNO (‘chronic POPNO’ group, n = 241). Questions relating to treatments and medications were completed by 88% of the respondents (1244/1420). The chronic POPNO group was more likely to receive multiple pain medications (37% versus 21% took two or more pain medications, P < 0.001) and stronger painkillers [e.g. opioids odds ratio 1.94; 95% confidence interval 1.10, 3.42]. Despite this, they reported less effective pain relief than the non-POPNO chronic pain group. Conclusion. Patients in primary care reporting chronic pain were found generally to obtain incomplete relief from their medication with chronic POPNO patients reporting less relief. It is important that patients with any chronic pain are identified and managed appropriately according to their distinct treatment needs.</description><subject>Adult</subject><subject>Aged</subject><subject>Analgesics - therapeutic use</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Central Nervous System Agents - therapeutic use</subject><subject>Chronic Disease</subject><subject>Chronic pain</subject><subject>Drugs</subject><subject>Female</subject><subject>Health Surveys</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neuralgia - drug therapy</subject><subject>Neuralgia - epidemiology</subject><subject>Neuralgia - therapy</subject><subject>neuropathic pain</subject><subject>Opioids</subject><subject>Outcome and Process Assessment (Health Care)</subject><subject>Pain Measurement</subject><subject>Parasympatholytics - therapeutic use</subject><subject>Physical Therapy Modalities - utilization</subject><subject>Prevalence</subject><subject>primary care</subject><subject>Primary health care</subject><subject>Primary Health Care - methods</subject><subject>Relief</subject><subject>S-LANSS</subject><subject>Severity of Illness Index</subject><subject>treatment</subject><subject>United Kingdom - epidemiology</subject><subject>Urban Health</subject><issn>0263-2136</issn><issn>1460-2229</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqF0c9rFDEUB_AgFrtWj14leBAv0-bH5NdRqu4KrV5UxEvIZjJu2p1kmmSw_e_NMoMFL3t6kPfJeyRfAF5hdI6Rohe9GcZkLuwwoJY8ASvcctQQQtRTsEKE04Zgyk_B85xvEEJCMPEMnGLBBZKoXYHba9d5a4qPAZrQwZKcKYMLBU7ZQR_gmPxg0gO0Jjk4Vlh7Gf7xZQftLsXgbT2tLvaVui4OPphQ9g8wuCnFemFXRUz-tw8vwElv9tm9XOoZ-P7p47fLTXP1df358v1VYxlmpeF4y0lviFGMdVQIte0Jl1QZY7ue2q0k1EjT8Q7VVq1UWdG3CClCsZWC0jPwdp47png3uVz04LN1-70JLk5Zc8kQk5QdhUwQhhXlRyGpy0mLDxPf_Adv4pRCfa3GSrGq5AE1M7Ip5pxcr5dP1hjpQ6h6DlXPoVb_ehk6bQfXPeolxQrezSBO49FZy26fi7v_h0261VxQwfTm5y-9_vBlfS03P_Sa_gUuUb0X</recordid><startdate>20071001</startdate><enddate>20071001</enddate><creator>Torrance, Nicola</creator><creator>Smith, Blair H</creator><creator>Watson, Margaret C</creator><creator>Bennett, Michael I</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7TK</scope><scope>7QJ</scope><scope>7X8</scope></search><sort><creationdate>20071001</creationdate><title>Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin</title><author>Torrance, Nicola ; Smith, Blair H ; Watson, Margaret C ; Bennett, Michael I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c515t-61b62fa2a955d3779bf26839aacdf3cb823a8ad6d079bad639c7f4009231c8733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Analgesics - therapeutic use</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Central Nervous System Agents - therapeutic use</topic><topic>Chronic Disease</topic><topic>Chronic pain</topic><topic>Drugs</topic><topic>Female</topic><topic>Health Surveys</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neuralgia - drug therapy</topic><topic>Neuralgia - epidemiology</topic><topic>Neuralgia - therapy</topic><topic>neuropathic pain</topic><topic>Opioids</topic><topic>Outcome and Process Assessment (Health Care)</topic><topic>Pain Measurement</topic><topic>Parasympatholytics - therapeutic use</topic><topic>Physical Therapy Modalities - utilization</topic><topic>Prevalence</topic><topic>primary care</topic><topic>Primary health care</topic><topic>Primary Health Care - methods</topic><topic>Relief</topic><topic>S-LANSS</topic><topic>Severity of Illness Index</topic><topic>treatment</topic><topic>United Kingdom - epidemiology</topic><topic>Urban Health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Torrance, Nicola</creatorcontrib><creatorcontrib>Smith, Blair H</creatorcontrib><creatorcontrib>Watson, Margaret C</creatorcontrib><creatorcontrib>Bennett, Michael I</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Neurosciences Abstracts</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>MEDLINE - Academic</collection><jtitle>Family practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Torrance, Nicola</au><au>Smith, Blair H</au><au>Watson, Margaret C</au><au>Bennett, Michael I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin</atitle><jtitle>Family practice</jtitle><addtitle>Fam Pract</addtitle><date>2007-10-01</date><risdate>2007</risdate><volume>24</volume><issue>5</issue><spage>481</spage><epage>485</epage><pages>481-485</pages><issn>0263-2136</issn><eissn>1460-2229</eissn><coden>FAPREH</coden><abstract>Background. Neuropathic pain is widely recognized as one of the most difficult pain syndromes to treat and presents a significant challenge for pain clinicians and GPs. Methods. The Self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire, recently validated for identifying pain of predominantly neuropathic origin (POPNO), was sent to 6000 adults identified from general practices in the UK. The questionnaire also contained items about chronic pain identification, medications and treatments received for pain and the pain relief these provided. Results. In total, 1420/3002 (48%) of respondents indicated that they suffered with any chronic pain. These were further categorized as those with chronic pain who were S-LANSS negative [‘chronic pain (non-POPNO)’ group, n = 1179] and those with chronic pain who were S-LANSS positive, indicating the presence of POPNO (‘chronic POPNO’ group, n = 241). Questions relating to treatments and medications were completed by 88% of the respondents (1244/1420). The chronic POPNO group was more likely to receive multiple pain medications (37% versus 21% took two or more pain medications, P < 0.001) and stronger painkillers [e.g. opioids odds ratio 1.94; 95% confidence interval 1.10, 3.42]. Despite this, they reported less effective pain relief than the non-POPNO chronic pain group. Conclusion. Patients in primary care reporting chronic pain were found generally to obtain incomplete relief from their medication with chronic POPNO patients reporting less relief. It is important that patients with any chronic pain are identified and managed appropriately according to their distinct treatment needs.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>17670804</pmid><doi>10.1093/fampra/cmm042</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0263-2136 |
| ispartof | Family practice, 2007-10, Vol.24 (5), p.481-485 |
| issn | 0263-2136 1460-2229 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68505835 |
| source | MEDLINE; Applied Social Sciences Index & Abstracts (ASSIA); Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Adult Aged Analgesics - therapeutic use Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Anticonvulsants - therapeutic use Antidepressive Agents - therapeutic use Central Nervous System Agents - therapeutic use Chronic Disease Chronic pain Drugs Female Health Surveys Humans Male Middle Aged Neuralgia - drug therapy Neuralgia - epidemiology Neuralgia - therapy neuropathic pain Opioids Outcome and Process Assessment (Health Care) Pain Measurement Parasympatholytics - therapeutic use Physical Therapy Modalities - utilization Prevalence primary care Primary health care Primary Health Care - methods Relief S-LANSS Severity of Illness Index treatment United Kingdom - epidemiology Urban Health |
| title | Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A49%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medication%20and%20treatment%20use%20in%20primary%20care%20patients%20with%20chronic%20pain%20of%20predominantly%20neuropathic%20origin&rft.jtitle=Family%20practice&rft.au=Torrance,%20Nicola&rft.date=2007-10-01&rft.volume=24&rft.issue=5&rft.spage=481&rft.epage=485&rft.pages=481-485&rft.issn=0263-2136&rft.eissn=1460-2229&rft.coden=FAPREH&rft_id=info:doi/10.1093/fampra/cmm042&rft_dat=%3Cproquest_cross%3E20922415%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=199592285&rft_id=info:pmid/17670804&rft_oup_id=10.1093/fampra/cmm042&rfr_iscdi=true |